应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
WHWK Whitehawk Therapeutics, Inc.
休市中 12-12 16:00:00 EST
2.32
-0.18
-7.20%
盘后
2.32
+0.00
0.00%
16:52 EST
最高
2.54
最低
2.24
成交量
13.65万
今开
2.47
昨收
2.50
日振幅
12.00%
总市值
1.09亿
流通市值
5,051万
总股本
4,713万
成交额
32.44万
换手率
0.63%
流通股本
2,177万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Whitehawk Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Whitehawk Therapeutics, Inc.于2007年11月16日在特拉华州成立。该公司是一家临床阶段的生物制药公司,为基因定义的癌症开发精准疗法。该公司的主要目标是为mTOR通路驱动因子变化的癌症患者带来转化疗法,例如TSC1或TSC2基因的变化,而mTOR抑制剂由于药理学、有效药物递送、安全性或有效性问题而没有或不能得到有效利用。Aadi的主要产品是FYARROTM,这是一种mTOR抑制剂,可与人类蛋白质结合,并显示出更高的肿瘤积累、更大的mTOR靶点抑制和增强的肿瘤生长抑制。
发行价格:
--
{"stockData":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":2.32,"timestamp":1765573200000,"preClose":2.5,"halted":0,"volume":136495,"hourTrading":{"tag":"盘后","latestPrice":2.32,"preClose":2.32,"latestTime":"16:52 EST","volume":389,"amount":905.161,"timestamp":1765576379566},"delay":0,"floatShares":21770230,"shares":47128362,"eps":-0.309934,"marketStatus":"休市中","change":-0.18,"latestTime":"12-12 16:00:00 EST","open":2.47,"high":2.54,"low":2.24,"amount":324411.788649,"amplitude":0.12,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.309934,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.5,"preHourTrading":{"tag":"盘前","latestPrice":2.44,"preClose":2.5,"latestTime":"09:18 EST","volume":613,"amount":1488.3895621000001,"timestamp":1765549109460},"postHourTrading":{"tag":"盘后","latestPrice":2.32,"preClose":2.32,"latestTime":"16:52 EST","volume":389,"amount":905.161,"timestamp":1765576379566},"volumeRatio":0.9893301220688607,"impliedVol":0.288,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/WHWK/tweets","defaultTab":"tweets","newsList":[],"profile":{"websiteUrl":"http://www.whitehawktx.com","stockEarnings":[{"period":"1week","weight":-0.0683},{"period":"1month","weight":0.0404},{"period":"3month","weight":0.1658},{"period":"6month","weight":0.1837},{"period":"1year","weight":-0.0373},{"period":"ytd","weight":-0.2647}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Whitehawk Therapeutics, Inc.于2007年11月16日在特拉华州成立。该公司是一家临床阶段的生物制药公司,为基因定义的癌症开发精准疗法。该公司的主要目标是为mTOR通路驱动因子变化的癌症患者带来转化疗法,例如TSC1或TSC2基因的变化,而mTOR抑制剂由于药理学、有效药物递送、安全性或有效性问题而没有或不能得到有效利用。Aadi的主要产品是FYARROTM,这是一种mTOR抑制剂,可与人类蛋白质结合,并显示出更高的肿瘤积累、更大的mTOR靶点抑制和增强的肿瘤生长抑制。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.179486},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.0383},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.227585},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.018337},{"month":5,"riseRate":0.857143,"avgChangeRate":0.190811},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.069397},{"month":7,"riseRate":0.375,"avgChangeRate":-0.025419},{"month":8,"riseRate":0.625,"avgChangeRate":0.031865},{"month":9,"riseRate":0.625,"avgChangeRate":0.003135},{"month":10,"riseRate":0.125,"avgChangeRate":-0.092738},{"month":11,"riseRate":0.625,"avgChangeRate":0.077853},{"month":12,"riseRate":0.375,"avgChangeRate":-0.089806}],"exchange":"NASDAQ","name":"Whitehawk Therapeutics, Inc.","nameEN":"Whitehawk Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Whitehawk Therapeutics, Inc.,WHWK,Whitehawk Therapeutics, Inc.股票,Whitehawk Therapeutics, Inc.股票老虎,Whitehawk Therapeutics, Inc.股票老虎国际,Whitehawk Therapeutics, Inc.行情,Whitehawk Therapeutics, Inc.股票行情,Whitehawk Therapeutics, Inc.股价,Whitehawk Therapeutics, Inc.股市,Whitehawk Therapeutics, Inc.股票价格,Whitehawk Therapeutics, Inc.股票交易,Whitehawk Therapeutics, Inc.股票购买,Whitehawk Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}